This category contains 3 posts

Prescription Drug Act Proves Crucial to Millions of Americans with Chronic Diseases

By Sandra C. Raymond, president and CEO, Lupus Foundation of America Ten years ago, most Americans had never heard of lupus – a chronic autoimmune disease. Today, through education and outreach, more people are becoming familiar with the serious impact lupus has on the health of an estimated 1.5 million Americans. With Congress actively considering … Continue reading

New Research Shows Promising Alternative to Methotrexate to Manage Inflammation

May 17, 2012 (Fort Lauderdale, Florida) — Mycophenolate mofetil (MMF) is superior to methotrexate for the treatment of ocular inflammatory diseases, according to a study presented here at the Association for Research in Vision and Ophthalmology 2012 Annual Meeting. Using a marginal structural model to simulate a clinical trial comparing the 2 agents, the researchers, … Continue reading

FDA Update on U.S. Methotrexate Shortage

Methotrexate is one of the medications my husband takes every week to manage his autoimmune disease, dermatomyositis. For the past 6 weeks, the shortage of injectable methotrexate has forced him to switch to the oral form. For some reason, these tiny pills make him feel nauseous, unlike the injection. It’s the same dosage, so I’m … Continue reading